Literature DB >> 23907316

Analysis of latent tuberculosis infection treatment adherence among refugees and other patient groups referred to the Baltimore City Health Department TB clinic, February 2009-March 2011.

Jennifer B Nuzzo1, Jonathan E Golub, Patrick Chaulk, Maunank Shah.   

Abstract

We sought to determine the proportion of refugee patients at the Baltimore City Health Department Tuberculosis program (BCHD-TB) successfully completing latent tuberculosis infection (LTBI) treatment, as compared to other referral groups, and to identify factors associated with treatment completion. We completed a retrospective cohort analysis of individuals referred to BCHD-TB program for LTBI care between February 1, 2009 and March 31, 2011. Among 841 patients evaluated by BCHD-TB and diagnosed with LTBI, 81% of refugees, 50% of non-refugee foreign-born, and 35% of US-born patients completed LTBI treatment. In multivariate analysis, refugees had greater odds of LTBI treatment completion (Adjusted Odds Ratio 7.2; 95% CI 4.2-12.4, p < 0.001) compared to US-born individuals adjusting for age, gender, and treatment regimen. Overall, LTBI treatment completion remains suboptimal. At BCHD-TB, LTBI treatment completion was significantly higher among refugees than other referral groups. Additional efforts are needed to optimize LTBI care, and future efforts may need to be tailored for different risk groups.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 23907316     DOI: 10.1007/s10903-013-9882-9

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  14 in total

Review 1.  Medication adherence in Hispanics to latent tuberculosis treatment: a literature review.

Authors:  Julie Ann Zuñiga
Journal:  J Immigr Minor Health       Date:  2012-02

2.  Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory.

Authors:  James M Trauer; Vicki L Krause
Journal:  Med J Aust       Date:  2011-06-06       Impact factor: 7.738

Review 3.  Clinical practice. Latent tuberculosis infection in the United States.

Authors:  C Robert Horsburgh; Eric J Rubin
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

4.  Changes in the transmission of tuberculosis in New York City from 1990 to 1999.

Authors:  Elvin Geng; Barry Kreiswirth; Cynthia Driver; Jiehui Li; Joseph Burzynski; Phyllis DellaLatta; Angel LaPaz; Neil W Schluger
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

5.  Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience.

Authors:  Y Hirsch-Moverman; J Bethel; P W Colson; J Franks; W El-Sadr
Journal:  Int J Tuberc Lung Dis       Date:  2010-09       Impact factor: 2.373

6.  Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.

Authors:  A Trajman; R Long; D Zylberberg; M J Dion; B Al-Otaibi; D Menzies
Journal:  Int J Tuberc Lung Dis       Date:  2010-05       Impact factor: 2.373

Review 7.  Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.

Authors:  P A LoBue; D A Enarson; T C Thoen
Journal:  Int J Tuberc Lung Dis       Date:  2010-10       Impact factor: 2.373

8.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

9.  Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada.

Authors:  J F Levesque; P Dongier; P Brassard; R Allard
Journal:  Int J Tuberc Lung Dis       Date:  2004-06       Impact factor: 2.373

10.  Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study.

Authors:  Neela D Goswami; Lara Beth Gadkowski; Carla Piedrahita; Deborah Bissette; Marshall Alex Ahearn; Michela L M Blain; Truls Østbye; Jussi Saukkonen; Jason E Stout
Journal:  BMC Public Health       Date:  2012-06-21       Impact factor: 3.295

View more
  13 in total

1.  Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.

Authors:  S Kapoor; A Gupta; M Shah
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

2.  High proportion of extrapulmonary tuberculosis in a low prevalence setting: a retrospective cohort study.

Authors:  J N Sama; N Chida; R M Polan; J Nuzzo; K Page; M Shah
Journal:  Public Health       Date:  2016-04-29       Impact factor: 2.427

3.  Impact of Routine Quantiferon Testing on Latent Tuberculosis Diagnosis and Treatment in Refugees in Multnomah County, Oregon, November 2009-October 2012.

Authors:  Jaime K Walters; Amy D Sullivan
Journal:  J Immigr Minor Health       Date:  2016-04

4.  Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department.

Authors:  Jennifer B Nuzzo; Jonathan E Golub; Patrick Chaulk; Maunank Shah
Journal:  Am J Public Health       Date:  2015-01-20       Impact factor: 9.308

Review 5.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

6.  Factors associated with noncompletion of latent tuberculosis infection treatment in an inner-city population in Edmonton, Alberta.

Authors:  Kathy Malejczyk; Jennifer Gratrix; Avril Beckon; Danusia Moreau; Gwenna Williams; Dennis Kunimoto; Rabia Ahmed
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-09       Impact factor: 2.471

7.  A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.

Authors:  La'Marcus T Wingate; Margaret S Coleman; Christopher de la Motte Hurst; Marie Semple; Weigong Zhou; Martin S Cetron; John A Painter
Journal:  BMC Public Health       Date:  2015-12-01       Impact factor: 3.295

8.  Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.

Authors:  Kieran Rustage; Jessica Lobe; Sally E Hayward; Kristina L Kristensen; Ioana Margineanu; Ymkje Stienstra; Delia Goletti; Dominik Zenner; Teymur Noori; Manish Pareek; Christina Greenaway; Jon S Friedland; Laura B Nellums; Sally Hargreaves
Journal:  Lancet Infect Dis       Date:  2021-08-04       Impact factor: 25.071

Review 9.  Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Authors:  Anke L Stuurman; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anouk M Oordt-Speets; Andreas Sandgren; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-06-08       Impact factor: 3.090

10.  Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.

Authors:  Andreas Sandgren; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anke Stuurman; Anouk Oordt-Speets; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.